{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T23:30:02Z","timestamp":1792884602733,"version":"4.5.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002850","name":"FONDECYT","doi-asserted-by":"publisher","award":["N\u00b01130724"],"award-info":[{"award-number":["N\u00b01130724"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"FONDECYT","doi-asserted-by":"publisher","award":["N\u00b01130271"],"award-info":[{"award-number":["N\u00b01130271"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002848","name":"CONICYT","doi-asserted-by":"publisher","award":["N\u00b0 PFB16"],"award-info":[{"award-number":["N\u00b0 PFB16"]}],"id":[{"id":"10.13039\/501100002848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013908","name":"Universidad Andr\u00e9s Bello","doi-asserted-by":"crossref","award":["DI-603-14\/N"],"award-info":[{"award-number":["DI-603-14\/N"]}],"id":[{"id":"10.13039\/501100013908","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Universidad San Sebasti\u00e1n","award":["USS 2011-0001-R"],"award-info":[{"award-number":["USS 2011-0001-R"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.bbr.2014.07.055","type":"journal-article","created":{"date-parts":[[2014,8,8]],"date-time":"2014-08-08T07:22:52Z","timestamp":1407482572000},"page":"186-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"special_numbering":"C","title":["Dopamine receptor D3 deficiency results in chronic depression and anxiety"],"prefix":"10.1016","volume":"274","author":[{"given":"Rodrigo","family":"Moraga-Amaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8057-9806","authenticated-orcid":false,"given":"Rodrigo","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Stehberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2014.07.055_bib0005","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0163-7258(94)90041-8","article-title":"Dopamine receptors: molecular biology, biochemistry and behavioural aspects","volume":"64","author":"Jackson","year":"1994","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bbr.2014.07.055_bib0010","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0028-3908(96)00100-1","article-title":"Dopamine receptors and brain function","volume":"35","author":"Jaber","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2014.07.055_bib0015","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1146\/annurev.pharmtox.39.1.313","article-title":"New insights into dopaminergic receptor function using antisense and genetically altered animals","volume":"39","author":"Sibley","year":"1999","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.bbr.2014.07.055_bib0020","doi-asserted-by":"crossref","first-page":"9175","DOI":"10.1073\/pnas.88.20.9175","article-title":"Multiple human D5 dopamine receptor genes: a functional receptor and two pseudogenes","volume":"88","author":"Grandy","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbr.2014.07.055_bib0025","first-page":"602","article-title":"Dopamine receptor pharmacology","volume":"6","author":"Seeman","year":"1993","journal-title":"Curr Opin Neurol Neurosurg"},{"key":"10.1016\/j.bbr.2014.07.055_bib0030","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0074-7742(08)60573-5","article-title":"Molecular neurobiology of dopaminergic receptors","volume":"35","author":"Sibley","year":"1993","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.bbr.2014.07.055_bib0035","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000017313","article-title":"Dopamine receptors and dopamine transporter in brain function and addictive behaviors: insights from targeted mouse mutants","volume":"20","author":"Drago","year":"1998","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.bbr.2014.07.055_bib0040","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","article-title":"Dopamine receptors: from structure to function","volume":"78","author":"Missale","year":"1998","journal-title":"Physiol Rev"},{"key":"10.1016\/j.bbr.2014.07.055_bib0045","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fncir.2013.00152","article-title":"Dopamine signaling in reward-related behaviors","volume":"7","author":"Baik","year":"2013","journal-title":"Front Neural Circuits"},{"key":"10.1016\/j.bbr.2014.07.055_bib0050","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/YCO.0b013e32835dc9da","article-title":"The pharmacogenetics of antipsychotic-induced adverse events","volume":"26","author":"Muller","year":"2013","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.bbr.2014.07.055_bib0055","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archpsyc.64.3.327","article-title":"The role of dopamine in the pathophysiology of depression","volume":"64","author":"Dunlop","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bbr.2014.07.055_bib0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1056\/NEJMra073096","article-title":"Major depressive disorder","volume":"358","author":"Belmaker","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbr.2014.07.055_bib0065","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature11740","article-title":"Dopamine neurons modulate neural encoding and expression of depression-related behaviour","volume":"493","author":"Tye","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2014.07.055_bib0070","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0014-2999(97)01407-6","article-title":"Effects of a psychostimulant drug sydnocarb on rat brain dopaminergic transmission in vivo","volume":"340","author":"Gainetdinov","year":"1997","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"10.1016\/j.bbr.2014.07.055_bib0075","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/ptr.4938","article-title":"Anti-depressant effects of aqueous extract from acanthopanax senticosus in mice","volume":"27","author":"Jin","year":"2013","journal-title":"Phytother Res"},{"key":"10.1016\/j.bbr.2014.07.055_bib0080","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-2999(03)01310-4","article-title":"Antidepressant-like actions of DOV 21,947: a \u201ctriple\u201d reuptake inhibitor","volume":"461","author":"Skolnick","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2014.07.055_bib0085","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1527-3458.2006.00123.x","article-title":"Preclinical and clinical pharmacology of DOV 216,303, a triple reuptake inhibitor","volume":"12","author":"Skolnick","year":"2006","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.bbr.2014.07.055_bib0090","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00415-006-0067-5","article-title":"Pramipexole versus sertraline in the treatment of depression in Parkinson's disease A national multicenter parallel-group randomized study","volume":"253","author":"Barone","year":"2006","journal-title":"J Neurol"},{"key":"10.1016\/j.bbr.2014.07.055_bib0095","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1034\/j.1399-5618.2002.01171.x","article-title":"Pramipexole in treatment-resistant depression: a 16-week naturalistic study","volume":"4","author":"Lattanzi","year":"2002","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.bbr.2014.07.055_bib0100","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00213-002-1166-3","article-title":"Bupropion occupancy of the dopamine transporter is low during clinical treatment","volume":"163","author":"Meyer","year":"2002","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.bbr.2014.07.055_bib0105","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/mds.25837","article-title":"Pramipexole reverses Parkinson's disease-related motivational deficits in rats","volume":"29","author":"Favier","year":"2014","journal-title":"Mov Disord"},{"key":"10.1016\/j.bbr.2014.07.055_bib0110","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/FBP.0b013e32830cd80f","article-title":"Animal models of depression in dopamine, serotonin, and norepinephrine transporter knockout mice: prominent effects of dopamine transporter deletions","volume":"19","author":"Perona","year":"2008","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.bbr.2014.07.055_bib0115","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbr.2013.10.035","article-title":"Induction of depressive-like behavior by intranigral 6-OHDA is directly correlated with deficits in striatal dopamine and hippocampal serotonin","volume":"259","author":"Santiago","year":"2014","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2014.07.055_bib0120","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/347146a0","article-title":"Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics","volume":"347","author":"Sokoloff","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2014.07.055_bib0125","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bbr.2013.01.019","article-title":"Effects of immobilization stress on emotional behaviors in dopamine D3 receptor knockout mice","volume":"243","author":"Xing","year":"2013","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2014.07.055_bib0130","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1460-9568.1994.tb00329.x","article-title":"Opposing roles for dopamine D2 and D3 receptors on neurotensin mRNA expression in nucleus accumbens","volume":"6","author":"Diaz","year":"1994","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bbr.2014.07.055_bib0135","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/0306-4522(94)00527-C","article-title":"Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain","volume":"65","author":"Diaz","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2014.07.055_bib0140","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0306-4522(02)00067-2","article-title":"Dopamine autoreceptor regulation of release and uptake in mouse brain slices in the absence of D(3) receptors","volume":"112","author":"Joseph","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2014.07.055_bib0145","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/sj.npp.1300677","article-title":"Antidepressant-like effect of D(2\/3) receptor-, but not D(4) receptor-activation in the rat forced swim test","volume":"30","author":"Basso","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2014.07.055_bib0150","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejphar.2009.06.029","article-title":"Antidepressant effects of pramipexole, a dopamine D3\/D2 receptor agonist, and 7-OH-DPAT, a dopamine D3 receptor agonist, in olfactory bulbectomized rats","volume":"616","author":"Breuer","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2014.07.055_bib0155","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1503\/jpn.110038","article-title":"Long-term administration of the dopamine D3\/2 receptor agonist pramipexole increases dopamine and serotonin neurotransmission in the male rat forebrain","volume":"37","author":"Chernoloz","year":"2012","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.bbr.2014.07.055_bib0160","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/JCP.0b013e31816774f9","article-title":"The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study","volume":"28","author":"Marcus","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.bbr.2014.07.055_bib0165","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12325-013-0004-9","article-title":"Cariprazine in bipolar disorder: clinical efficacy, tolerability, and place in therapy","volume":"30","author":"Citrome","year":"2013","journal-title":"Adv Ther"},{"key":"10.1016\/j.bbr.2014.07.055_bib0170","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1440-1819.2008.01814.x","article-title":"Temporal cortex dopamine D2\/3 receptor binding in major depression","volume":"62","author":"Lehto","year":"2008","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.bbr.2014.07.055_bib0175","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s002130050791","article-title":"Effect of antidepressant drugs on dopamine D1 and D2 receptor expression and dopamine release in the nucleus accumbens of the rat","volume":"140","author":"Ainsworth","year":"1998","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2014.07.055_bib0180","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/sj.mp.4000754","article-title":"Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments","volume":"5","author":"Lammers","year":"2000","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bbr.2014.07.055_bib0185","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0091-3057(81)90007-1","article-title":"Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines","volume":"15","author":"Crawley","year":"1981","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2014.07.055_bib0190","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/BF02327579","article-title":"Genetic analysis of anxiety-related behaviors and responses to benzodiazepine-related drugs in AXB and BXA recombinant inbred mouse strains","volume":"25","author":"Mathis","year":"1995","journal-title":"Behav Genet"},{"key":"10.1016\/j.bbr.2014.07.055_bib0195","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.neubiorev.2005.03.008","article-title":"Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.bbr.2014.07.055_bib0200","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","article-title":"The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.bbr.2014.07.055_bib0205","first-page":"1","article-title":"Rodent models of depression: forced swim and tail suspension behavioral despair tests in rats and mice","author":"Castagne","year":"2011","journal-title":"Curr Protoc Neurosci"},{"key":"10.1016\/j.bbr.2014.07.055_bib0210","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF02244188","article-title":"An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress","volume":"104","author":"Papp","year":"1991","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2014.07.055_bib0215","doi-asserted-by":"crossref","first-page":"6227","DOI":"10.1073\/pnas.1034823100","article-title":"Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression","volume":"100","author":"El Yacoubi","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbr.2014.07.055_bib0220","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0014-2999(78)90414-4","article-title":"Behavioural despair in rats and mice: strain differences and the effects of imipramine","volume":"51","author":"Porsolt","year":"1978","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2014.07.055_bib0225","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2014.07.055_bib0230","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/BF00187257","article-title":"Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant","volume":"93","author":"Willner","year":"1987","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2014.07.055_bib0235","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.biopsych.2007.06.024","article-title":"Antidepressant treatment can normalize adult behavioral deficits induced by early-life exposure to methylphenidate","volume":"63","author":"Bolanos","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2014.07.055_bib0240","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1073\/pnas.93.5.1945","article-title":"A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice","volume":"93","author":"Accili","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbr.2014.07.055_bib0245","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0896-6273(00)80965-4","article-title":"Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors","volume":"19","author":"Xu","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.bbr.2014.07.055_bib0250","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0306-4522(98)00705-2","article-title":"Potentiation of the D2 mutant motor phenotype in mice lacking dopamine D2 and D3 receptors","volume":"91","author":"Jung","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2014.07.055_bib0255","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.phrs.2008.09.002","article-title":"Dopamine receptor 3 (D3) knockout mice show regular emotional behaviour","volume":"58","author":"Chourbaji","year":"2008","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.bbr.2014.07.055_bib0260","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1472-8206.2004.00287.x","article-title":"Dopamine, depression and antidepressants","volume":"18","author":"Dailly","year":"2004","journal-title":"Fundam Clin Pharmacol"},{"issue":"Suppl. 6","key":"10.1016\/j.bbr.2014.07.055_bib0265","first-page":"3","article-title":"The role of dopamine and norepinephrine in depression and antidepressant treatment","volume":"67","author":"Nutt","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.bbr.2014.07.055_bib0270","first-page":"112","article-title":"Monoamine oxidases in major depressive disorder and alcoholism","volume":"6","author":"Duncan","year":"2012","journal-title":"Drug Discov Ther"},{"key":"10.1016\/j.bbr.2014.07.055_bib0275","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1073\/pnas.0307921101","article-title":"Lithium antagonizes dopamine-dependent behaviors mediated by an AKT\/glycogen synthase kinase 3 signaling cascade","volume":"101","author":"Beaulieu","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbr.2014.07.055_bib0280","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1523\/JNEUROSCI.5074-06.2007","article-title":"Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo","volume":"27","author":"Beaulieu","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2014.07.055_bib0285","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1038\/npp.2010.105","article-title":"Is glycogen synthase kinase-3 a central modulator in mood regulation","volume":"35","author":"Li","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2014.07.055_bib0290","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejphar.2013.06.034","article-title":"Intracellular pathways of antipsychotic combined therapies: implication for psychiatric disorders treatment","volume":"718","author":"de Bartolomeis","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2014.07.055_bib0295","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1176\/appi.ajp.2009.08121873","article-title":"Roles of the Akt\/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action","volume":"167","author":"Freyberg","year":"2010","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.bbr.2014.07.055_bib0300","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejphar.2013.07.022","article-title":"Dopamine D(3) receptor as a new pharmacological target for the treatment of depression","volume":"719","author":"Leggio","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2014.07.055_bib0305","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1517\/17425255.2013.759211","article-title":"Cariprazine: chemistry, pharmacodynamics, pharmacokinetics, and metabolism, clinical efficacy, safety, and tolerability","volume":"9","author":"Citrome","year":"2013","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.bbr.2014.07.055_bib0310","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1017\/S1092852900020216","article-title":"Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants","volume":"14","author":"Berman","year":"2009","journal-title":"CNS Spectr"},{"key":"10.1016\/j.bbr.2014.07.055_bib0315","doi-asserted-by":"crossref","first-page":"843","DOI":"10.4088\/JCP.v68n0604","article-title":"The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study","volume":"68","author":"Berman","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.bbr.2014.07.055_bib0320","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clinthera.2009.01.012","article-title":"The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies","volume":"31","author":"Leentjens","year":"2009","journal-title":"Clin Ther"},{"key":"10.1016\/j.bbr.2014.07.055_bib0325","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.euroneuro.2007.07.003","article-title":"Increased sensitivity to antidepressants of D3 dopamine receptor-deficient mice in the forced swim test (FST)","volume":"18","author":"Leggio","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.bbr.2014.07.055_bib0330","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.euroneuro.2010.05.006","article-title":"Dopamine D3 receptor knock-out mice exhibit increased behavioral sensitivity to the anxiolytic drug diazepam","volume":"21","author":"Leggio","year":"2011","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.bbr.2014.07.055_bib0335","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0166-4328(01)00231-5","article-title":"A comparison of 129S2\/SvHsd and C57BL\/6JOlaHsd mice on a test battery assessing sensorimotor, affective and cognitive behaviours: implications for the study of genetically modified mice","volume":"124","author":"Contet","year":"2001","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2014.07.055_bib0340","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.bcp.2012.06.023","article-title":"Medication discovery for addiction: translating the dopamine D3 receptor hypothesis","volume":"84","author":"Newman","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bbr.2014.07.055_bib0345","first-page":"57","article-title":"A systematic review of augmentation strategies for patients with major depressive disorder","volume":"42","author":"Fleurence","year":"2009","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.bbr.2014.07.055_bib0350","series-title":"Stahl's essential psychopharmacology neuroscientific basis and practical applications, New York","author":"Stahl","year":"2008"},{"key":"10.1016\/j.bbr.2014.07.055_bib0355","doi-asserted-by":"crossref","first-page":"e54108","DOI":"10.1371\/journal.pone.0054108","article-title":"The functional DRD3 Ser9Gly polymorphism (rs6280) is pleiotropic, affecting reward as well as movement","volume":"8","author":"Savitz","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2014.07.055_bib0360","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/JCP.0b013e318267b6da","article-title":"DRD3, but not BDNF, genotype affects treatment response to paroxetine in major depressive disorder: a preliminary study","volume":"32","author":"Tsuchimine","year":"2012","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.bbr.2014.07.055_bib0365","doi-asserted-by":"crossref","first-page":"599","DOI":"10.4088\/JCP.08m04632gre","article-title":"Genetic association study of treatment response with olanzapine\/fluoxetine combination or lamotrigine in bipolar I depression","volume":"71","author":"Perlis","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.bbr.2014.07.055_bib0370","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00210-005-0020-7","article-title":"Absence of amino acid-induced glomerular hyperfiltration in dopamine D3 receptor knockout mice","volume":"372","author":"Luippold","year":"2006","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.bbr.2014.07.055_bib0375","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0031-9384(97)00430-7","article-title":"D3 dopamine receptor-deficient mouse: evidence for reduced anxiety","volume":"63","author":"Steiner","year":"1997","journal-title":"Physiol Behav"},{"key":"10.1016\/j.bbr.2014.07.055_bib0380","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neulet.2010.09.025","article-title":"Dopamine D3 receptor knock-out mice display deficits in locomotor sensitization after chronic morphine administration","volume":"485","author":"Li","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bbr.2014.07.055_bib0385","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0028-3908(98)00213-5","article-title":"Dopamine D3 receptor agonists produce similar decreases in body temperature and locomotor activity in D3 knock-out and wild-type mice","volume":"38","author":"Boulay","year":"1999","journal-title":"Neuropharmacology"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432814005117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432814005117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:04:36Z","timestamp":1759064676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432814005117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":77,"alternative-id":["S0166432814005117"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2014.07.055","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dopamine receptor D3 deficiency results in chronic depression and anxiety","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2014.07.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}